急性缺血性卒中重组组织型纤溶酶原激活剂溶栓后口舌血管性水肿:2例报道
被引量:3
Orolingual angioedema after rtPA treatment of acute stroke: a report of two cases
摘要
重组组织型纤溶酶原激活剂(recombinant tisue plasminogen activator,rtPA)治疗急性缺血性卒中的效果已得到许多大样本临床试验的支持。随着溶栓治疗经验的积累,对其不良反应的认识也在不断深入。血管神经性水肿是一种发生于皮下疏松组织或黏膜的暂时性、局限性、无痛性水肿,可分为获得性和遗传性。
出处
《国际脑血管病杂志》
北大核心
2014年第2期158-160,共3页
International Journal of Cerebrovascular Diseases
基金
上海市虹口区卫生局重点课题(虹卫1202-07)
参考文献15
-
1Hill MDI, Lye T, Moss H, et al.Hemi-orolingual angioedema and ACE inhibition after alteplase treatment of stroke. Neurology, 2003,60: 1525-1527.
-
2Cicardi M, Zingale Le, Bergamaschini L, et al. Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment. Arch Intem Med, 2004, 164: 910-913.
-
3Hernandez-Hernandez R, Sosa-Canache B, Velasco M, et al. Angiotensin Il receptor antagonists role in arterial hypertension.J Hum Hypertens, 2002, 16(Suppll): S93-S99.
-
4Grossman E, Messerli FH, NeutelJM. Angiotensin n receptor blockers: equal or preferred substitutes for ACE inhibitors? Arch Intern Med, 2000, 160: 1905 -1911.
-
5Lo KS. Angioedema associated with candesartan. Pharmacotherapy, 2002,22: 1176-1179.
-
6Pancioli A, frott T, Donaldson V, et al. Asymmetric angioneurotic edema associated with thrombolysis for acute stroke. Ann Emerg Med, 1997,30: 227-229.
-
7Hill MD, Barber P A, TakahashiJ, et al. Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke. CMAJ, 2000, 162: 1281-1284.
-
8Wang CT, Lin FC, Khor GT, et al. Life-threatening anaphylactoid shock caused by recombinant tissue plasminogen activator. AmJ Emerg Med, 2012, 30: 253el-253e2.
-
9Haymore BR, YoonJ, Mikita CP, et al. Risk of angioedema with angiotensin receptor blockers in patients with prior angioedema associated with angiotensin-converting enzyme inhibitors: a meta-analysis. Ann Allergy Asthma Immunol, 2008, 101: 495- 499.
-
10NussbergerJ, Koike H. Antagonizing the angiotensin n subtype I receptor: a focus on ohnesartan medoxomil. Coo Ther, 2004, 26 (Suppl A): Al2-A20.
同被引文献14
-
1Sobolewski P,Brola W,Szczuchniak W,et al.Safety of intravenous thrombolysis for acute ischaemic stroke including concomitant neoplastic disease sufferers experience from Poland[J].International Journal of Clinical Practice,2015,69(6):666-673.
-
2Engelter ST,Fluri F,Buitrago-Téllez C,et al.Life-threatening orolingual angioedema during thrombolysis in acute ischemic stroke[J].J Neurol,2005,252(10):1167-1170.
-
3Yayan J.Effects of alteplase in the treatment of acute ischemic stroke.International Journal of General Medicine[J].2012,2012(5):743-751.
-
4S.-Y.Lin,S.-C.Tang,L.-K.Tsai,et al.Orolingual angioedema after alteplase therapy of acute ischaemicstroke:incidence and risk of prior angiotensinconverting enzyme inhibitor use[J].Eur J Neurol,2014,21(10):1285-1291.
-
5Jennifer E.Fugate,Ejaaz A.Kalimullah,Eelco F.M.Wijdicks.Angioedema after t PA:what neurointensiv-ists should know[J].Neurocritical Care,2012,16:440-443.
-
6Hill MD,Barber PA,Takahashi J,et a1.Anaphylactoid reactions and angioedema during alteplase treat-ment of acute ischemic stroke[J].CMAJ,2000,162(9):1281-1284.
-
7Hill Michael D,Barber Philip A,Takahashi J,et al.Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke[J].Canadian Medical Association Journal,2000,162(9):1281-1284.
-
8Hill MDl,Lye T,Moss H,et a1.Hemiorolingual angioedema and ACE inhbition after akephse treatmentof stroke[J].Neurology,2003,60:1525-1527.
-
9Wang CT,Lin FC,Khor GT,et a1.Life-threatening anaphylactoid shock caused by recombinant tissueptasminogen activator[J].Am JEmerg Med,2012,30:253el-253e2.
-
10Madden B,Chebl RB.Hemi Orolingual Angioedema after t PA Administration for Acute Ischemic Stroke[J].West J Emerg Med,2015,16(1):175-177.
引证文献3
-
1赵春红,唐海霞,潘婷婷.4例脑梗死静脉溶栓后口舌血管性水肿的护理体会[J].中医临床研究,2015,7(31):142-143. 被引量:1
-
2王凤,郑周,王莹,金笑平,虞丹,刘素芝,柯绍发.急性脑梗死患者阿替普酶溶栓致过敏2例并文献复习[J].心脑血管病防治,2017,17(1):66-68. 被引量:8
-
3庄福聚,宋晓文,庄伟,范雪丽,董晓梦,李斌.卒中患者静脉溶栓后口舌部血管性水肿:2例报道并文献复习[J].国际脑血管病杂志,2020,28(10):795-800. 被引量:1
二级引证文献9
-
1周晶亮,管晓东,吴忻晶,彭宾宾.阿替普酶致急性脑梗死患者过敏反应并发外周血肿[J].药物不良反应杂志,2018,20(3):226-227. 被引量:1
-
2宋田佳.阿替普酶溶栓治疗急性脑梗死的临床效果及对神经功能的影响[J].系统医学,2018,3(19):37-38. 被引量:3
-
3李姗.优质护理在急性脑梗死静脉溶栓治疗中的应用效果[J].重庆医学,2018,47(A01):136-138.
-
4方海霞.临床护理路径在阿替普酶静脉溶栓治疗急性脑梗死患者中的应用效果[J].中国当代医药,2019,26(6):226-228. 被引量:11
-
5郝星,刘楚杰.银杏叶提取物联合阿替普酶静脉溶栓治疗急性脑梗死的临床疗效观察[J].实用医技杂志,2020,27(4):510-511. 被引量:4
-
6陈念,沈晓朴.急性缺血性卒中患者阿替普酶静脉溶栓相关性荨麻疹:2例报道并文献复习[J].国际脑血管病杂志,2022,30(3):232-235.
-
7温咏平,黄强,邹金连.阿替普酶溶栓所致药品不良反应的文献分析[J].临床合理用药杂志,2024,17(20):166-168.
-
8赵彩霞.急性脑梗死治疗中阿替普酶与尿酸激酶的疗效与安全性对比研究[J].医药论坛杂志,2019,0(5):153-155. 被引量:4
-
9王淑环.急性脑梗死阿替普酶静脉溶栓治疗临床探讨[J].双足与保健,2017,26(24):120-120. 被引量:1
-
1王晋予,李方,常际平.缬沙坦与卡托普利治疗高血压的疗效对比探析[J].中国医药指南,2013,11(18):510-511. 被引量:5
-
2李爱玲.中西医结合治疗早期糖尿病肾病的疗效探讨[J].求医问药(下半月刊),2012,10(6):845-845. 被引量:9
-
3董高宏,张衍国,王欢,王志刚,王小霞,吕雅杰.以头皮血管性水肿为皮肤表现的系统性红斑狼疮1例分析[J].中国误诊学杂志,2010,10(15):3767-3768.
-
4王佳佩,吴菱,王天波,郑吉卡,狄亚珍,戴霞华.伴血管神经性水肿的过敏性紫癜患儿预后及治疗[J].临床荟萃,2017,32(1):68-70. 被引量:9
-
5周红.第三代溶栓剂的作用特点及其研究现状[J].国外医学(心血管疾病分册),2000,27(5):274-276. 被引量:16
-
6兰强,廖晓菲.氯沙坦治疗慢性充血性心力衰竭86例临床分析[J].现代医药卫生,2005,21(22):3103-3103.
-
7于波,宫丽鸿.四妙勇安汤联合西药对急性冠状动脉综合征热壅血瘀证患者PCI术后t-PA及MCP-1的影响[J].中国中西医结合杂志,2012,32(3):419-421. 被引量:5
-
8李宏建.在延长的“时间窗”内进行静脉溶栓治疗的效果[J].国际脑血管病杂志,2015,23(9):703-703.
-
9李宏建.静脉溶栓治疗的排除标准存在性别差异[J].国际脑血管病杂志,2015,23(5):398-398.
-
10王丽华.75岁以上急性心肌梗死静脉溶栓32例临床分析[J].中国社区医师(医学专业),2006,8(1):11-12.